Introduction
============

Oral cancer is one of the most common cancers in the head as well as neck region, and is a major public health issue worldwide. It develops on the tongue, lips, gum, salivary glands, buccal mucosa, palate, and even the floor of mouth. There were 300,000 estimated new cases in 2012 worldwide, with two thirds developing in men ([@b1-ol-0-0-10609]). Although oral cancer is ranked as the 15th most common cancer, it is often not diagnosed until a very advanced stage and the lethality of 50% has caused much concern ([@b1-ol-0-0-10609]). Moreover, recent data suggested that the incidence of oral cancer has highly increased in the last two decades ([@b2-ol-0-0-10609],[@b3-ol-0-0-10609]). The vast majority of oral cancer is derived from the multi-layered squamous epithelium and is referred to as oral squamous cell carcinoma (OSCC). Three major lifestyle factors, namely areca nut chewing, alcohol consumption, and smoking are generally considered as main causative factors for oral cancer. Genetic confounders, however, are of great interest but remain unclear.

Polymorphisms are prevalent genetic loci, which play a vital role during the process of human traits. Single-nucleotide polymorphisms (SNPs) are low penetrate genetic variants, which are found to be associated with cancer susceptibility ([@b4-ol-0-0-10609]). DNA repair genes prevent the genome from being damaged, which are due to endogenic or environmental carcinogens. The defect in DNA repair system is proved to induce pre-cancerous lesions and cancers ([@b5-ol-0-0-10609]). In this regard, it is natural to make the hypothesis that part of the genetic variants with DNA repairing genes may influence the DNA repair ability and infer susceptibility of oral cancer. X-ray repair cross-complementing group 3 *(XRCC3)*, located mainly on chromosome 14q32.3, belongs to the RAD51 family. It has been proven to participate in double strand break and homologous recombination repair ([@b6-ol-0-0-10609]). It is one of the most important genes related to DNA repair. The Thr241Met (18607C/T, rs861539) polymorphism, a C/T substitution in exon seven, has resulted in a Thr-to-Met amino-acid alteration. It has drawn wide attention as its variant influences repair capacity for DNA damage, and has been confirmed to be related to increased risk of various cancers ([@b7-ol-0-0-10609]--[@b9-ol-0-0-10609]). Moreover, previous research has investigated the association regarding Thr241Met polymorphism to the risk of oral cancer. However, the data are inconclusive ([@b10-ol-0-0-10609]--[@b16-ol-0-0-10609]). For example, the 241Met allele showed a \>3-fold increased risk for oral cancer in Thai population ([@b10-ol-0-0-10609]), while no significant association was identified in Brazilian patients ([@b13-ol-0-0-10609]). This discrepancy may be due to various aspects. From a statistical perspective, studies with relatively inadequate sample sizes have low power to identify low penetric genetic variants. On the other hand, the lack of reproducibility might also be due to discrepant genetic or lifestyle backgrounds. To solve the inconsistence of previous studies and verify the association of *XRCC3* Thr241Met polymorphisms and oral cancer risk meta-analysis was conducted using the most recent published datasets.

Materials and methods
=====================

### Search strategy for identification of associated studies

An extensive literature review was conducted by using Embase, Medline, PubMed, Wanfang and CNKI online resources. Related papers published from January 2000 to September 2017 were selected. In order to include both English and Chinese-language articles, the keywords '*XRCC3 or* X-ray repair cross-complementing protein 3', 'polymorphism or SNP', 'oral cancer or oral squamous cell carcinoma' and their combinations were utilized as well as the relevant Chinese characters were chosen in searches of the Chinese database. To filter and include more related articles, bibliography listed in the retrieved papers was manually searched. If there were multiple articles from the same authors or research groups, the most recent data or the largest datasets were included.

### Inclusion and exclusion criteria

All the selected studies had to be covered by the following inclusion criteria: case-and-control studies that focused on the association study of *XRCC3* Thr241Met polymorphisms regarding oral cancer risk. Distribution of genotypes and allele information of patients or controls were accessible, or with the odds ratio (OR) with its 95% confidence intervals (CIs). The criteria of exclusion included: review articles or abstracts from conferences; studies without control group or data were not available to be extracted.

The study was approved by the Ethics Committee of the Second Affiliated Hospital of Soochow University (Suzhou, China). Patients or their guardians signed an informed consent.

### Statistical analysis

In the present meta-analysis, *XRCC3* Thr241Met polymorphism between patients and controls was compared by the unadjusted ORs and 95% CIs. Significance of the pooled ORs is indicated and tested via Z-test. The Mantel-Haenszel model using the χ^2^ test was performed to estimate heterogeneity between different groups. The following five genetic models were performed to assess the association between the Thr241Met polymorphism and oral cancer: allele model (Met vs. Thr), homozygous model (Met/Met vs. Thr/Thr), dominant model (Met/Met + Thr/Met vs. Thr/Thr), heterozygous model (Met/Thr vs. Thr/Thr) and recessive model (Met/Met vs. Thr/Met + Thr/Thr). Between-study heterogeneity was captured by the inconsistency index I^2^ test along with the statistic Q-test. Fixed effect model was employed in case of homologous effects (P\>0.01 and I^2^ \<50%). Random-effect model was utilized when the effects were heterogeneous (P\<0.01 and I^2^ \>50%). Egger regression asymmetry test and funnel plots were utilized to validate publication bias. Probability ≤0.05 was considered as significant with the exception of the I^2^ statistic and Egger\'s test, when a significant level of \<0.1 was applied. STATA version 11.0 for Windows was used for statistical analyses and data management.

### Data extraction and quality assessment

Two independent investigators performed extraction of data. Disagreements were solved by adjustments of the third investigator through achieving a consensus. The following information was included: year of publication, the first author, sample size, country, genotyping methods, ethnicity, the Hardy-Weinberg equilibrium (HWE) in controls, and allele and genotype distribution.

Results
=======

### Study identification and inclusion

In summary, 15 relevant studies were kept after the above-mentioned searches. Using the inclusion and exclusion criteria, finally 7 studies were selected, which include 1,615 oral cancer cases and 1,897 related controls. The 7 articles were from studies of five countries and regions, mainly involving two ethnicities (3 groups of Caucasians and 4 groups of Asians). Sample sizes of the data ranged from 92 to 1744. Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) method was applied for SNP genotype. Detailed information is provided in [Table I](#tI-ol-0-0-10609){ref-type="table"}.

### Association of XRCC3 Thr241Met SNP regarding overall oral cancer risk

There are seven articles that contain 1,615 oral cancer patients and 1,897 controls. Heterogeneity of the involved literature was analyzed. The fixed effect and random effect models were respectively utilized. Despite the fact that T allele frequency is rather high in patients comparing with controls (16.7% vs. 14.4%), our analyses did not infer a significant association between the T allele and oral cancer susceptibility (T vs. C: OR=1.20, 95% CI=0.92--1.57, P=0.18) by applying the random effect model ([Fig. 1](#f1-ol-0-0-10609){ref-type="fig"}). Neither was significance identified by using heterozygous model (CT vs. CC: OR=0.96, 95% CI=0.60--1.55, heterogeneity P=0.001, I^2^=81.3%, [Fig. 2](#f2-ol-0-0-10609){ref-type="fig"}), dominant model (CT + TT vs. CC: OR=1.08, 95% CI=0.73--1.59, heterogeneity P=0.001, I^2^=74.5%, [Fig. 3](#f3-ol-0-0-10609){ref-type="fig"}); homozygous model (CC vs. TT: OR=1.33, 95% CI=0.91--1.96, heterogeneity P=0.13, I^2^=41.6%, [Fig. 4](#f4-ol-0-0-10609){ref-type="fig"}); However, as shown in [Fig. 5](#f5-ol-0-0-10609){ref-type="fig"}, a significant relationship was identified for the recessive model. TT genotype was positively associated with oral cancer risk (TT vs. CT + CC: OR=1.81, P=0.001, 95% CI=1.28--2.57, heterogeneity P=0.155, I^2^=37.6%).

### Publication bias and sensitivity analysis

As there was substantial heterogeneity among studies during the process of comprehensive comparisons, sensitivity analyses were performed to indicate the effect of each single data against the aggregated ORs. The recalculated ORs are not substantially influenced, suggesting that our results are reliable and they verify the hardiness of the present investigation. The Egger\'s test and funnel plots were applied to validate potential bias from the published literature. Shape of the funnel plots is approximately symmetrical. Egger\'s test result shows no statistical evidence for bias (P\>0.05), indicating that there is no obvious bias in this meta-analysis based on the searched publications and the results are plausible ([Fig. 6](#f6-ol-0-0-10609){ref-type="fig"}).

### Stratified analyses by ethnicity and areca nut chewing

In the ethnicity stratified analysis, more significant associations were detected in Asian population. (Asians: homozygous model CC vs. TT: OR=2.15, 95% CI=1.11--4.17, P=0.02, heterogeneity P=0.67, I^2^=0.0%, [Fig. 7](#f7-ol-0-0-10609){ref-type="fig"}; recessive model CT + CC vs. TT: OR=2.14, 95% CI=1.11--4.14, P=0.02, heterogeneity P=0.78, I^2^=0.0%, [Fig. 8](#f8-ol-0-0-10609){ref-type="fig"}; heterozygous model CC vs. CT: OR=1.20, 95% CI=0.80--1.81, P=0.38, heterogeneity P=0.04, I^2^=63.9%; dominant model CC vs. TT + CT: OR=1.25, P=0.29, 95% CI=0.83--1.88, heterogeneity P=0.03, I^2^=66.2%; allele C vs. T: OR=1.28, 95% CI=0.87--1.88, P=0.21, heterogeneity P=0.03, I^2^=67.5%). No significant association were identified in Caucasians: (homozygous model CC vs. TT: OR=1.09, 95% CI=0.47--2.53, P=0.84, heterogeneity P=0.09, I^2^=57.7%; recessive model CT + CC vs. TT: OR=1.43, 95% CI=0.57--3.61, P=0.45, heterozygous model CC vs. CT: OR=0.75, 95% CI=0.25 - 2.27, P=0.61, heterogeneity P=0.001, I^2^=87.1%; dominant model CC vs. TT + CT: OR=0.92, P=0.82, 95% CI=0.92--1.95, heterogeneity P=0.02, I^2^=66.2%; heterogeneity P=0.03, I^2^=71.9%; allele C vs. T: OR=1.11, 95% CI=0.74--1.69, P=0.61, heterogeneity P=0.05, I^2^=66.4%). Three studies included areca nut chewing for stratified analysis, which allowed for further analysis ([Table II](#tII-ol-0-0-10609){ref-type="table"}). There was no significant association between the T allele carrier and oral cancer risk in people without areca nut chewing habit (OR=1.40, 95% CI=0.81--2.43, p=0.23, heterogeneity P=0.30, I^2^=16.9%). In the areca nut chewers, T allele carrier had significantly higher risk of oral cancer (OR=1.81, 95% CI=1.26--2.61, P=0.001, heterogeneity P=0.10, I^2^=56.3%, [Fig. 9](#f9-ol-0-0-10609){ref-type="fig"}).

Discussion
==========

DNA repairing systems play an indispensable role in protecting cells against carcinogenic agents. It is largely accepted that environmental carcinogens would stimulate DNA damage, which would then induct genomic instability ([@b17-ol-0-0-10609]). In this manner, alternations in DNA repairing genes may potentially influence the susceptibility of each disease, which would affect therapy as well as prognosis ([@b18-ol-0-0-10609]--[@b20-ol-0-0-10609]). In the current study, we verified the association between *XRCC3* Thr241Met polymorphism and oral cancer risk. Results illustrated that TT (Met/Met) genotype was associated with high risk of oral cancer through the recessive model (P=0.001). Further stratification analyses demonstrated that the Met/Met genotype was significantly associated with oral cancer under both recessive and homozygous models in Asians (P\<0.05). In contrast, no association was detected regarding *XRCC3* Thr241Met polymorphisms to oral cancer risk in non-Asians.

*XRCC3*, a paralog of RAD51 protein, functions in homologous recombination repair (HRR) pathway and maintaining genomic stability in mammalian cells. The Thr241Met polymorphism resides in an evolutionary conserved region, the adenosine triphosphate-binding domain, which is the exclusive region with certain functional activity of *XRCC3* protein ([@b21-ol-0-0-10609]). The Thr241Met polymorphism is suggested to have a possible mechanic function in the protein structure ([@b22-ol-0-0-10609]). For instance, *XRCC3* 241Met has been shown to be functionally deficient in repairing X-ray inducted chromosome aberrations, which infer that the genotyping of the variant is defective in the base excision repair (BER) ([@b23-ol-0-0-10609]). Several epidemiological studies have indicated that there was an association between *XRCC3* polymorphisms and oral cancer susceptibility, whereas a large amount of results remained contradictory. In the current study, the Met/Met genotype of Thr241Met polymorphism associated with high risk oral cancer was validated, which is consistent with previous functional studies. People with TT(Met/Met) genotype may have a defect in DNA repair function thus they are more susceptible to cancer, while those who have one and/or two Thr allele may have appropriate function which protects against cancer ([@b23-ol-0-0-10609]). People with homozygous of Met allele and defect in HRR function may be more susceptible to cancer, while those who have one and/or two Thr allele may have normal function which protects them against cancer. Moreover, by analysis of gene-environment interactions, comparison of the CC genotype demonstrated that the Met allele carriers had significantly increased risk of oral cancer in areca nut chewers, but not in those without this habit. As areca nut chewing may induce mitochondrial DNA mutation and oxidative DNA damage ([@b24-ol-0-0-10609],[@b25-ol-0-0-10609]), and people with the XRCC3 241Met allele and functional deficient in repair of DNA mutations may be susceptible to development of cancer. However, we were not able to perform further analysis with limited information regarding smoking, alcohol drinking and genotyping.

So far, there is only one meta-analysis report regarding the association of *XRCC3* Thr241Met polymorphism to oral cancer risk reporting that *XRCC3* Thr241Met polymorphism is irrelevant to the risk of oral cancer ([@b26-ol-0-0-10609]). However, the authors included upper aero-digestive cancer and leukoplakia, a common precancer lesion, in their association analysis. Biology may differ from tumors of different origins, for example, Benhamou *et al* ([@b27-ol-0-0-10609]) found that there is no significant association between the *XRCC3* polymorphism and cancer of the upper aerodigestive tract. Analysis of widely determined cancer sites may lead to inconclusive results. In our analysis, more focused research on homogeneous cancer sites have reduced variations and are able to find a moderate association between *XRCC3* Thr241Met polymorphism and oral cancer risk.

It is also important to note that the distributions of SNPs are highly different in various ethnic populations. Therefore, ethnicity may be a confounder. Previous association studies were performed in different populations, which may raise the discrepancy. For instance, the distribution of the *XRCC3* Thr241Met variant genotypes (Thr/Met and Met/Met) was 14.0 and 0.6%, respectively, in the Thai population ([@b10-ol-0-0-10609]). The distribution was 20.0 and 4.0%, respectively, in Brazil population ([@b11-ol-0-0-10609]); 34.5 and 2.3% in Indian population ([@b15-ol-0-0-10609]); 54.7 and 26.4% in Turkish population ([@b14-ol-0-0-10609]); 7.6 and 0.5% in Taiwan Chinese ([@b16-ol-0-0-10609]). From these results, it could be speculated that Chinese population may be more resistant to environmental carcinogens due to the fact that the population carry the Thr allele more frequently comparing with other populations. On the other hand, both Brazilian and Turkish populations are highly heterogeneous populations, with a mixture of European, Asian and African populations. In our study, stratification analysis illustrated that there was no significant association regarding *XRCC3* Thr241Met polymorphism to oral cancer risk in these populations, indicating ethnic heterogeneity may affect the overall result of association studies.

Preliminary data show that the variant Met allele affects the development of oral cancer. The Met/Met genotype is also associated with at least 8-fold increase of the risk for developing metastases. With respect to clinical diagnosis and practice, the Met/Met genotype was associated with a fairly high risk of developing oral cancer at either stage III or IV ([@b11-ol-0-0-10609]). In addition, the genotype of *XRCC3* Thr241Met polymorphism was reported to be associated with tumor size ([@b14-ol-0-0-10609]). However, further studies using large populations are required to confirm these findings.

Finally, the potential of a polymorphism to impair DNA repair activity may be affected by other polymorphic alleles interfering in the process. For example, those nucleotide excision repairing genes for repair of smoking-induced DNA damage were not included in this study. We could not rule out a possibility that the Thr241Met polymorphism is within linkage disequilibrium regions with polymorphic genotype of other DNA repair genes. Therefore, further investigations exploring main contribution factors will be performed in the future to better understand the susceptibility phenomenon regarding oral cancer.

We suggest that the homozygote variants of Thr241Met polymorphism regarding *XRCC3* possibly act as factors for oral cancer risk. Moreover, the increased oral cancer risk was more obviously enhanced in Asians, but not in other populations. This study provides insight into whether DNA repair gene polymorphisms play an indispensable role in changing individual susceptibility to oral cancer. Further validations of gene-environment and gene-gene connections are necessary to explore the effects of *XRCC3* Thr241Met polymorphisms on oral cancer.
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###### 

Main characteristics of included studies in this meta-analysis.

                                                                                     Genotype and allele information                                                                            
  -------------------------------------------------- ------ ---------- ------ ------ --------------------------------- ----- ----- -------- ------- ------ ------- ----- ------- ------- ------ ----------
  Avci *et al* ([@b14-ol-0-0-10609])                 2017   Turkey     111    148      34                              25    52      93     129       28     81    39      137   159     0.22   PCR-RFLP
  Kietthubthew *et al* ([@b10-ol-0-0-10609])         2006   Thailand   106    164      83                              22      1     188      24    140      23      1     303     25    0.96   PCR-RFLP
  Majumder *et al* ([@b15-ol-0-0-10609])             2005   India      310    348    201                               97    12      499    121     220    120       8     560   136     0.07   PCR-RFLP
  Dos Reis *et al* ([@b13-ol-0-0-10609])             2012   Brazil     144    144      63                              72      9     198      90      52     78    14      182   106     0.05   PCR-RFLP
  dos Santos Pereira *et al* ([@b11-ol-0-0-10609])   2015   Brazil       53     39     10                              34      9       54     52      15     20      4     50      28    0.48   PCR-RFLP
  Tsai *et al* ([@b16-ol-0-0-10609])                 2014   China      788    956    684                               92    12    1460     116     878      73      5   1829      83    0.01   PCR-RFLP
  Yang *et al* ([@b12-ol-0-0-10609])                 2015   China      103      98     96                                7     0     199        7     89       9     0     187       9   0.63   PCR-RFLP

HWE, the Hardy-Weinberg equilibrium. PCR-RFLP, polymerase chain reaction restriction fragment length polymorphism.

###### 

Association of areca nut chewing, *XRCC3* Thr241Met polymorphism and oral cancer risk.

  Life style First authors (Refs.)               Genotypes   Adjusted OR   95% CI       P-value
  ---------------------------------------------- ----------- ------------- ------------ ---------
  No areca nut chewing                                                                  
    Kietthubthew *et al* ([@b10-ol-0-0-10609])   CT/TT         2.61        0.97--7.11   0.06
    Yang *et al* ([@b12-ol-0-0-10609])           CT/TT       0.5           0.0--11.5    N/A
    Tsai *et al* ([@b16-ol-0-0-10609])           CT/TT       1.1           0.56--2.17   0.86
  Areca nut chewing                                                                     
    Kietthubthew *et al* ([@b10-ol-0-0-10609])   CT/TT         2.85        0.72--11.3   0.14
    Yang *et al* ([@b12-ol-0-0-10609])           CT/TT       0.4           0.1--1.9     N/A
    Tsai *et al* ([@b16-ol-0-0-10609])           CT/TT         1.94        1.31--2.87     0.001

N/A, not applicable. *XRCC3*, X-ray repair cross complementing group 3.

[^1]: Contributed equally
